What Researchers Did
The researchers reviewed studies from 2015 to 2021 to check whether hyperbaric oxygen therapy (HBOT) is an effective treatment for children and youth with autism spectrum disorder (ASD).
What They Found
This literature review found that HBOT was not confirmed as an effective therapy for autism spectrum disorder, based on 10 literature reviews and 4 intervention studies. None of the 10 literature reviews said HBOT was a clearly effective therapy for ASD. Two of the four intervention studies also did not recommend HBOT for children with ASD. Of the other two, one had no control group and the other looked only at auditory processing disorders, so they were not fully relevant to the review's purpose. Overall, the review concluded that the literature does not confirm that HBOT significantly affects ASD symptoms.
What This Means for Canadian Patients
The abstract notes that many parents and guardians try HBOT for a child with ASD, based on a suggested pathophysiological rationale. This review found no clear evidence of effectiveness in the studies it examined. Families considering HBOT for a child with ASD may want to discuss this finding with their child's doctor.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The review included only articles from 2015 to 2021, and of the four intervention studies, one had no control group and one focused only on auditory processing disorders, which limits what the review can conclude.